Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 4/20 | 0.46 |
| ▸ | F2 | P00734 | 3/20 | 0.46 |
| ▸ | F12 | P00748 | 1/20 | 0.42 |
| ▸ | F7 | P08709 | 1/20 | 0.42 |
| ▸ | F3 | P13726 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.39 |
| ▸ | C1S | P09871 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | WDR5 | P61964 | 1/20 | 0.37 |
| ▸ | MRGPRX1 | Q96LB2 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL128193 | 0.82 | CA1 (0.56) | F10F2HTTMRGPRX1CA12 | |
| SCHEMBL25707413 | 0.82 | F10 (0.44) | F10F2F12F7F3 | |
| SCHEMBL29970206 | 0.82 | CA1 (0.56) | F10F2HTTMRGPRX1CA12 | |
| Hydrochloric Acid SCHEMBL3284355 | 0.80 | CA1 (0.54) | F10F2HTTMRGPRX1CA12 | |
| Hydrochloric Acid SCHEMBL31037950 | 0.80 | CA1 (0.54) | F10F2HTTMRGPRX1CA12 | |
| SCHEMBL10495281 | 0.79 | F2 (0.55) | F10F2F12F7F3 | |
| SCHEMBL23249713 | 0.79 | KDM4E (0.44) | F10F2BLMCTNNB1PRSS1 | |
| SCHEMBL9857038 | 0.79 | LMNA (0.51) | F2PRSS1PRSS2PRSS3C1S | |
| SCHEMBL3085720 | 0.79 | CTNNB1 (0.67) | F10F2CTNNB1KMT2AHTT | |
| SCHEMBL2564929 | 0.77 | HCRTR1 (0.53) | PRSS1PRSS2PRSS3KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220241180-A1 | COMPOSITION COMPRISING SORBITOL OR XYLITOL, AND A GELLING AGENT | COSMETIC WARRIORS LIMITED (GB) | 2022-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220241180-A1 | COMPOSITION COMPRISING SORBITOL OR XYLITOL, AND A GELLING AGENT | SORD, ALDOA, DCXR | F10 439/4885F2 1566/4885F12 121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.